Vanderbilt University Medical Center

Running trials

• Not yet recruiting

  Multi-Modal Digital Monitoring of Disease Symptoms Huntington's Disease

  NCT07315984· BioSensics· Source

• Not yet recruiting

  PhII Study of Toripalimab Followed by Definitive CRT & Adjuvant Toripalimab in Locally Advanced ESCC

  NCT07836049· Phase 2· Vanderbilt-Ingram Cancer Center· Source

• Recruiting

  Glucagon-Like Peptide-1 Receptor Agonists to Attenuate Metabolic Risk in Individuals With Duchenne Muscular Dystrophy

  NCT07642635· Phase 1/2· Vanderbilt University Medical Center· Source

• Not yet recruiting

  HMB Plus Vitamin D to Preserve Muscle in Older Adults Starting Semaglutide

  NCT07760948· Phase 2· Vanderbilt University Medical Center· Source

• Recruiting

  Study to Evaluate the Safety and Effectiveness of ELEVIDYS in Participants With Duchenne Muscular Dystrophy Treated in a Post-Marketing Setting

  NCT07542314· Phase 4· Sarepta Therapeutics, Inc.· Source

• Enrolling by invitation

  Alzheimer's Tau Platform: Regimen A - AADvac1

  NCT07167966· Phase 2· Paul S. Aisen· Source

• Not yet recruiting

  IKS04 Regimen in Advanced Solid Tumors That Express CA242

  NCT07738939· Phase 1· Iksuda Therapeutics Ltd.· Source

• Recruiting

  Window Trial of Intratumoral (IT) Neoadjuvant Fluorescently Labelled Nivolumab (nivo800) in Head and Neck Squamous Cell Carcinoma (HNSCC)

  NCT07741565· Early phase 1· Vanderbilt-Ingram Cancer Center· Source

• Recruiting

  Effect of an Isolevuglandin Scavenger on Salt Sensitivity of Blood Pressure and Immune Cell Activation in Humans

  NCT07602166· Phase 2· Vanderbilt University Medical Center· Source

• Recruiting

  Evaluation of the TAP-Preschool (TAP-P) for Tele-assessment of Autism in Preschool-aged Children

  NCT07932665· Vanderbilt University Medical Center· Source

• Recruiting

  Transition to Ambulatory Bariatric Surgery (TABS) Trial

  NCT07011628· Vanderbilt University Medical Center· Source

• Recruiting

  Study Evaluating the Safety and Feasibility of Panitumumab-IRDye800 and [18F]NOTA-ABY-030 for Targeted Dual-Modality Imaging (TDMI) in Head and Neck Squamous Cell Carcinoma

  NCT07741643· Phase 1· Vanderbilt-Ingram Cancer Center· Source

• Recruiting

  Bexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic Syndromes

  NCT07672769· Phase 2· Faron Pharmaceuticals Ltd· Source

• Recruiting

  A Study of CHM-029 in Participants With NPM1 Mutated, KMT2A or NUP98 Rearranged AML

  NCT07751991· Phase 1· Charm Therapeutics· Source

• Recruiting

  Casdatifan for the Treatment of Refractory Metastatic Clear Cell Renal Cell Carcinoma

  NCT07748988· Phase 1· Vanderbilt-Ingram Cancer Center· Source

• Not yet recruiting

  Impact of Dysport on PMFF Donor Scar

  NCT07720726· Phase 4· Vanderbilt University Medical Center· Source

• Recruiting

  A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia

  NCT07623200· Phase 3· Incyte Corporation· Source

• Enrolling by invitation

  Individual vs Co-Treatment in Acute Stroke Rehabilitation and Evaluation

  NCT07411534· Vanderbilt University Medical Center· Source

• Not yet recruiting

  2-Hydroxybenzylamine (2-HOBA) Study in Early Alzheimer's Patients

  NCT06432166· Phase 1/2· MTI Biotech Inc· Source

• Recruiting

  Atomoxetine in Melanocortin Obesity Syndrome

  NCT06899178· Phase 2· Icahn School of Medicine at Mount Sinai· Source

• Recruiting

  Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures

  NCT07594119· Phase 3· Rapport Therapeutics Inc.· Source

• Recruiting

  A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy

  NCT07771465· Phase 3· Kardigan, Inc.· Source

• Recruiting

  A Comparison of Cyclic Manual Direct Aspiration Thrombectomy (Plunger Technique) vs. Static Manual Direct Aspiration Thrombectomy for Treatment of Acute Large Vessel Occlusion Stroke

  NCT07231380· Vanderbilt University Medical Center· Source

• Recruiting

  Cryoablation for Monomorphic Ventricular Tachycardia (VTS)

  NCT07650032· Adagio Medical· Source

• Recruiting

  A Study of Electronic Clinical Decision Support Tools for Steatotic Liver Disease

  NCT07382349· Vanderbilt University Medical Center· Source

• Recruiting

  Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures

  NCT07493447· Early phase 1· Eben Rosenthal· Source

• Recruiting

  Alzheimer's Tau Platform: Master Protocol

  NCT06957418· Phase 2· Paul S. Aisen· Source

• Recruiting

  Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)

  NCT07460765· Phase 1· Vanderbilt-Ingram Cancer Center· Source

• Recruiting

  A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

  NCT07365241· Phase 3· AbbVie· Source

• Recruiting

  Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy

  NCT07172971· Phase 1· Vanderbilt University Medical Center· Source

• Recruiting

  ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)

  NCT07559903· Emory University· Source

• Recruiting

  Pridopidine Phase 3 Study in Huntington's Disease

  NCT07609108· Phase 3· Prilenia· Source

• Active, not recruiting

  ColoSeal™ ICD System Anastomotic Protection Pivotal Study

  NCT07429110· Averto Medical, Inc.· Source

• Recruiting

  A Study of CSTI-500 in Patients With Prader-Willi Syndrome

  NCT07348601· Phase 2· ConSynance Therapeutics· Source

• Recruiting

  A Study of TAK-755 in Adults With Acute Ischemic Stroke

  NCT07392450· Phase 2· Takeda· Source

• Recruiting

  PrP-targeting siRNA Safety & Mechanism Study

  NCT07444580· Phase 1· Broad Institute of MIT and Harvard· Source

• Recruiting

  2-HOBA in Systemic Lupus Erythematosus

  NCT07225543· Phase 2· Vanderbilt University Medical Center· Source

• Recruiting

  The HOPE Biobank Resource (BMT CTN 2402 HOPE)

  NCT07227155· Medical College of Wisconsin· Source

• Recruiting

  Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell Carcinoma

  NCT07217028· Phase 1· Vanderbilt-Ingram Cancer Center· Source

• Recruiting

  An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)

  NCT07365332· Phase 3· Inhibikase Therapeutics· Source

• Recruiting

  Identifying Effective and Cost-Conscious Maintenance Daratumumab Dosing

  NCT07485647· Phase 2· Eden Biltibo· Source

• Recruiting

  A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

  NCT07226843· Phase 1· Eli Lilly and Company· Source

• Recruiting

  GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV

  NCT07221214· Phase 2· Vanderbilt University Medical Center· Source

• Recruiting

  Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy

  NCT06828588· Early phase 1· Vanderbilt-Ingram Cancer Center· Source

• Enrolling by invitation

  Comparison of Post-Craniotomy Blood Pressure Targets

  NCT07093151· Vanderbilt University Medical Center· Source

• Recruiting

  Mechanistic Study of Nicotinamide Riboside on NAD+ Biology in Individuals With Combined Pulmonary Hypertension

  NCT07563322· Vanderbilt University Medical Center· Source

• Recruiting

  Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)

  NCT07298473· Medtronic Cardiac Ablation Solutions· Source

• Recruiting

  Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy

  NCT07144319· Photocure· Source

• Recruiting

  Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention

  NCT07473778· Gilead Sciences· Source

• Recruiting

  A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)

  NCT07291076· Phase 1/2· Bristol-Myers Squibb· Source

Showing 50 of 426.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• High blood pressure21 recruiting
• Head and neck cancer16 recruiting
• Colorectal cancer13 recruiting
• Obesity12 recruiting
• Parkinson disease11 recruiting
• Pulmonary arterial hypertension11 recruiting
• Stroke11 recruiting
• Pancreatic cancer10 recruiting
• Childhood cancers9 recruiting
• Heart failure9 recruiting
• Bladder cancer8 recruiting
• Epilepsy8 recruiting
• Lung cancer8 recruiting
• Gastric and oesophageal cancer7 recruiting
• Ovarian cancer7 recruiting
• Type 2 diabetes7 recruiting
• Chronic kidney disease6 recruiting
• Coronary artery disease6 recruiting
• Duchenne muscular dystrophy6 recruiting
• Peripheral artery disease6 recruiting
• Type 1 diabetes6 recruiting
• Alzheimer disease5 recruiting
• Aortic stenosis5 recruiting
• Fatty liver disease (MASLD/MASH)5 recruiting
• Kidney cancer5 recruiting
• Multiple system atrophy5 recruiting
• Sarcoma5 recruiting
• Ventricular tachycardia5 recruiting
• Acute myeloid leukaemia4 recruiting
• Cystic fibrosis4 recruiting
• Huntington's disease4 recruiting
• Liver cirrhosis4 recruiting
• Myelodysplastic syndromes4 recruiting
• Tourette syndrome4 recruiting
• Congenital heart disease3 recruiting
• Diffuse large B-cell lymphoma3 recruiting
• Follicular lymphoma3 recruiting
• Haemophilia3 recruiting
• Hearing loss3 recruiting
• HIV3 recruiting
• Idiopathic pulmonary fibrosis3 recruiting
• Melanoma3 recruiting
• Metastatic breast cancer3 recruiting
• Multiple myeloma3 recruiting
• Myeloproliferative neoplasms3 recruiting
• Systemic sclerosis (scleroderma)3 recruiting
• Triple-negative breast cancer3 recruiting
• Aortic aneurysm2 recruiting
• Atrial fibrillation2 recruiting
• Autism2 recruiting
• Cervical cancer2 recruiting
• Chronic myeloid leukaemia2 recruiting
• Crohn's disease2 recruiting
• Dilated cardiomyopathy2 recruiting
• Essential tremor2 recruiting
• Glioblastoma2 recruiting
• Liver and biliary tract cancer2 recruiting
• Lupus (SLE)2 recruiting
• Meningioma2 recruiting
• Mesothelioma2 recruiting
• Obstructive sleep apnoea2 recruiting
• Prostate cancer2 recruiting
• Schizophrenia2 recruiting
• Acute lymphoblastic leukaemia1 recruiting
• ALS (motor neurone disease)1 recruiting
• Amyloidosis1 recruiting
• Aplastic anaemia1 recruiting
• Asthma1 recruiting
• Bipolar disorder1 recruiting
• Brain aneurysm1 recruiting
• Coeliac disease1 recruiting
• COPD1 recruiting
• Depression1 recruiting
• Dermatomyositis and polymyositis (myositis)1 recruiting
• Fabry disease1 recruiting
• Familial hypercholesterolaemia1 recruiting
• Frontotemporal dementia1 recruiting
• Gaucher disease1 recruiting
• Hodgkin lymphoma1 recruiting
• Hydrocephalus1 recruiting
• Hypertrophic cardiomyopathy1 recruiting
• Insomnia1 recruiting
• Lewy body dementia1 recruiting
• Neuroendocrine tumours1 recruiting
• Osteoarthritis1 recruiting
• Osteoporosis1 recruiting
• Polycystic kidney disease1 recruiting
• Pompe disease1 recruiting
• Postural tachycardia syndrome (POTS)1 recruiting
• Sickle cell disease1 recruiting
• Thalassaemia1 recruiting
• Thyroid cancer1 recruiting

Researchers

• MAMelinda C Aldrich

Closed trials

• Withdrawn

  10 Degree C Static Storage in Heart Transplantation

  NCT07818941· John Trahanas· Source

• Withdrawn

  Milieu Teaching-AV (MT-AV Pilot)

  NCT06794476· Father Flanagan's Boys' Home· Source

• Withdrawn

  Intraoperative Identification and Stimulation of the Glossopharyngeal Nerve

  NCT05754216· Vanderbilt University Medical Center· Source

• Completed

  Project VOICES: Vocal Optimization in Children Elevating the Spectrum

  NCT06875843· Vanderbilt University Medical Center· Source

• Recruiting

  Thrombectomy Using Pulsed Aspiration for Reperfusion of Brain Occlusions

  NCT06029491· RapidPulse, Inc· Source

• Completed

  Description of Patients With Type 1 Diabetes Treated With Teplizumab

  NCT06892002· Sanofi· Source

• Completed

  Evaluating the Effectiveness of a Multi-level Health-Related Social Needs Initiative

  NCT06831162· Vanderbilt University Medical Center· Source

• Completed

  A Study to Assess Adults With CIDP Transitioning From IVIg to Efgartigimod PH20 SC

  NCT06637072· Phase 4· argenx· Source

• Completed

  Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS)

  NCT06593600· Phase 2· Regeneron Pharmaceuticals· Source

• Completed

  Prevention of Malnutrition in Children With Sickle Cell Disease

  NCT06397118· Vanderbilt University Medical Center· Source

• Completed

  ADVENT Trial Long Term Outcomes Evaluating Atrial Fibrillation Progression Study

  NCT06526546· Boston Scientific Corporation· Source

• Withdrawn

  REVERSE-Long COVID-19 With Baricitinib Study

  NCT05858515· Phase 3· Vanderbilt University Medical Center· Source

• Completed

  Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal Epilepsy

  NCT06377930· Phase 2· Rapport Therapeutics Inc.· Source

• Completed

  Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion Carriers

  NCT06667414· Hoffmann-La Roche· Source

• Terminated

  Double-blind, Randomized, Placebo-controlled Study Evaluating Efficacy and Safety of IgPro20 in Post-COVID-19 POTS

  NCT06524739· Phase 3· CSL Behring· Source

• Completed

  Statin Reminders for Improving Prescribing in Primary Care

  NCT06456658· Vanderbilt University Medical Center· Source

• Completed

  A Study to Learn About How Well BAY3283142 Works and Its Safety in Participants With Chronic Kidney Disease

  NCT06522997· Phase 2· Bayer· Source

• Completed

  Piloting Eye Movement Desensitization and Reprocessing (EMDR) Therapy in People Living With HIV and Trauma

  NCT06730867· Vanderbilt University Medical Center· Source

• Withdrawn

  Comparison of Amitriptyline to Lifestyle Modification as Intervention for Vestibular Migraine

  NCT06417684· Early phase 1· Vanderbilt University Medical Center· Source

• Terminated

  NM32-2668 in Adult Patients With Selected Advanced Solid Tumors

  NCT06299163· Phase 1· Numab Therapeutics AG· Source

• Completed

  Virtual Nephrologist

  NCT06841016· University of Pennsylvania· Source

• Completed

  RECOVER-AUTONOMIC Platform Protocol

  NCT06305780· Phase 2· Kanecia Obie Zimmerman· Source

• Recruiting

  A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

  NCT06072482· Phase 4· Amgen· Source

• Completed

  Shockwave Lithoplasty Compared to Cutting Balloon Treatment in Calcified Coronary Disease - A Randomized Controlled Trial

  NCT06089135· Baim Institute for Clinical Research· Source

• Terminated

  Defining the Risk of Ventricular Tachycardia in Genetic Forms of Early-onset Atrial Fibrillation

  NCT06647459· Vanderbilt University Medical Center· Source

• Completed

  Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study

  NCT06234488· Medical College of Wisconsin· Source

• Terminated

  Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis

  NCT06097260· Phase 2· Pliant Therapeutics, Inc.· Source

• Terminated

  Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas

  NCT05580588· Phase 2· Shanghai Pharma Biotherapeutics USA Inc.· Source

• Completed

  Use of MRI and cTBS for Catatonia in Autism

  NCT06016764· Phase 1· Vanderbilt University Medical Center· Source

• Completed

  Dynamic Quantification of Social-Visual Engagement in Autism Spectrum Disorder (ASD)

  NCT05806216· EarliTec Diagnostics, Inc· Source

• Completed

  Effects of My Diabetes Care on Patient Outcomes

  NCT05451914· Vanderbilt University Medical Center· Source

• Completed

  FORWARD PAD IDE Study With the Shockwave Javelin IVL Catheter

  NCT05858905· Shockwave Medical, Inc.· Source

• Completed

  Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCM

  NCT05767346· Phase 3· Cytokinetics· Source

• Completed

  Network-Targeted Neuromodulation for Nicotine Dependence in Schizophrenia

  NCT06389266· Vanderbilt University Medical Center· Source

• Completed

  Use of Hand-held Dynamometry to Obtain Objective Measures of Lower Extremity Force Production With Chronic Stroke

  NCT05941962· Vanderbilt University Medical Center· Source

• Completed

  A Biomarker Study of ATH434 in Participants With MSA

  NCT05864365· Phase 2· Alterity Therapeutics· Source

• Completed

  A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors

  NCT05712356· Phase 2· Lisata Therapeutics, Inc.· Source

• Completed

  Comprehensive Postpartum Management for Women With Hypertensive Disorders of Pregnancy

  NCT05849103· Vanderbilt University Medical Center· Source

• Completed

  A Study of Immune Checkpoint Inhibitor Combinations With Axitinib in Participants With Untreated Locally Advanced Unresectable or Metastatic Renal Cell Carcinoma

  NCT05805501· Phase 2· Hoffmann-La Roche· Source

• Completed

  To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPF

  NCT05483907· Phase 2· Bridge Biotherapeutics, Inc.· Source

• Completed

  A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen

  NCT05769608· Phase 2· Mineralys Therapeutics Inc.· Source

• Completed

  Effect of Donepezil on Speech Recognition in Cochlear Implant Users

  NCT05438264· Early phase 1· Vanderbilt University Medical Center· Source

• Completed

  Intraoperative Ansa Cervicalis Nerve (ACN) Stimulation

  NCT05650710· Vanderbilt University Medical Center· Source

• Completed

  Retrieval Practice for Word Learning for Deaf and Hard of Hearing Children

  NCT05512000· Vanderbilt University Medical Center· Source

• Completed

  Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults

  NCT05615220· Phase 3· Emalex Biosciences Inc.· Source

• Completed

  Visualization of the Papilla Through Use of the NuView Device in Patients With FAP

  NCT05657145· Vanderbilt University Medical Center· Source

• Terminated

  A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202)

  NCT05600426· Phase 3· Boston Children's Hospital· Source

• Terminated

  A Study of CNTY-101 in Participants With CD19-Positive B-Cell Malignancies

  NCT05336409· Phase 1· Century Therapeutics, Inc.· Source

• Completed

  Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection

  NCT05616221· Phase 2· Armata Pharmaceuticals, Inc.· Source

• Completed

  My Diabetes Care: A Scalability and Usability Study

  NCT05448105· Vanderbilt University Medical Center· Source

Showing 50 of 217.

Conditions

Diseases this institution publishes on or runs trials for.

• Heart failure209 works · 20 trials
• HIV183 works · 8 trials
• Alzheimer disease175 works · 17 trials
• Obesity161 works · 25 trials
• Stroke133 works · 27 trials
• Asthma98 works · 3 trials
• Lung cancer93 works · 22 trials
• Type 2 diabetes79 works · 16 trials
• Chronic kidney disease66 works · 18 trials
• Colorectal cancer63 works · 28 trials
• Tuberculosis59 works · 0 trials
• Prostate cancer55 works · 8 trials
• Epilepsy52 works · 13 trials
• Melanoma48 works · 8 trials
• Atrial fibrillation48 works · 14 trials
• Coronary artery disease44 works · 14 trials
• Gastric and oesophageal cancer43 works · 14 trials
• Multiple myeloma43 works · 10 trials
• Schizophrenia41 works · 6 trials
• Congenital heart disease38 works · 3 trials
• Hearing loss38 works · 8 trials
• Pulmonary arterial hypertension37 works · 17 trials
• Multiple sclerosis34 works · 5 trials
• Sickle cell disease33 works · 7 trials
• Acute myeloid leukaemia32 works · 14 trials
• Triple-negative breast cancer31 works · 9 trials
• Kidney cancer30 works · 15 trials
• Duchenne muscular dystrophy29 works · 9 trials
• COPD26 works · 2 trials
• Type 1 diabetes26 works · 10 trials